FDA Investigator Derek S Dealy
Derek S Dealy has inspections in 18 countries as of 18 Apr 2024. Derek S Dealy has collaborated with a combined 2786 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
165
Last Inspection Date:
18 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Dominican Republic,
Panama,
Viet Nam,
Jamaica,
United Arab Emirates,
Italy,
Japan,
Thailand,
Norway,
Spain,
Mexico,
Belize,
Grenada,
Canada,
Trinidad and Tobago,
South Africa
Co-Investigator(s):
Alan D Centi,
Alison N Correll,
Anastasia M Shields,
Anita R Michael,
Ann Marie Karnick,
Anna Lazar,
Annemarie Bodnar,
Ashley N Williams,
Audrey Thereset Uy,
Barbara J Rincon,
Bonita S Chester,
Brandon J Brookens,
Brian D Young,
Carol A Perry,
Carol A Robles,
CDR Michael J Mero,
Celena Ngo,
Charles D Brown,
Charles E Idjagboro,
Christina K Theodorou,
Clara E Santiago,
Craig D Zagata,
Crayton Lee,
Dana D Carter, SR DDS,
Daniel J Grabicki,
Daniel W Johnson,
Dauksism,
David A Oluwo,
David A Schwartz,
David P King,
David P Moorhead,
Dawn D Aiello,
Deborah G Haney Cozzone,
Debra D Devlieger,
Debra J Bennett,
Devon Jenkins,
Diana M Rand,
Donyel M Jones,
Dr. Jason R Caballero,
Edward D Mcdonald,
Edward Oshaughnessy,
Edwin L Hobbs,
Elizabeth D Connell,
Eric S Myskowski,
Erika M Wilkerson,
Gayle S Lawson,
Gerald W Kopp,
Gess,
Giovanni A Vigilante,
Grant L Davis,
Hala L Selby,
Herbert M Corbello,
Howard B Rabinovitch,
James M Mason,
James P Mcevoy,
Jane Chen,
Jane M Broussard,
Jason P Aun,
Jeannie R Mayberry,
Jeen S Min,
Jennifer A Bazergui,
Jennifer M Pouget,
Jennifer Macmillan,
Jill M Sooter,
Jo Annc Declement,
John A Daubenspeck,
John T Sproul,
Jon C Polzine,
Joseph L Despins, PhD,
Joseph S Fanelli,
Joseph T Dougherty,
Joshua C Schafer,
Judith A Jones,
Judith A Paterson,
Judith Paterson,
Julianne C Mccullough,
Junho Pak,
Karen D Phung,
Karen F Tomaziefski,
Karyn M Campbell,
Kathryn G Brown,
Kendra L Brooks,
Kim G Campbell,
King,
Kris K Moore,
Kristina J Donohue,
Kyle S Hobson,
Lakecha N Lewis,
Laura A Munsterman,
Linda M Hoover,
Linda M Ross,
Lori A Rose,
LT John M Mastalski,
LTJG Bradley E Benasutti,
LTJG Lauren N Shade,
Luis A Dasta,
Marc A Jackson, Jr,
Marcelo O Mangalindan, Jr,
Martha Sullivan Myrick,
Mary C Wall,
Matther R Noonan,
Matthew R Noona,
Matthew R Noonan,
Maureen A Wentzel,
Mcgrewp,
Meena Bansal Gupta, PhD,
Melissa M Dauksis,
Melissa M Schafer,
Meredith L Sheridan,
Michael A Taylor,
Michael L Casner,
Michael Rosner,
Mike M Rashti,
Nancy M Lazzari,
Nikisha M Bolden,
Pamela M Tremarki,
Paul L Bellamy,
Peter T Erlandson,
Raffi B Papazian,
Raymond A Lyn, Jr,
Raymond L Cheung,
Raymond M Lam,
Rebecca A Coleman,
Robert B Shibuya, MD,
Ronald T Colucci,
Rupa Pradhan,
Russell P Vandermark,
Ruth A Oni,
Samantha J Bradley,
Sara Jdent Acosta,
Sarah J Park,
Sarah K Lemin,
Schultz,
Sean D Duke,
Seng Ching Hwang,
Sharon Mills,
Shelagh D Schopen,
Simone M Edmonson,
State Agency,
Stephanie Mangigian, MS/OSH, RN,
Steven D Kehoe,
Steven M Weinman,
Sullivanm,
Susan F Laska, MS,
Tammy L Chavis,
Tania E Vizcaino,
Teigan M Mule,
Thomas E Friel,
Thomas J Hudson,
Todd J Maushart,
Tonya O Corbin,
Travers,
Valerie A Potopsingh,
Van Cliff,
Vlada Matusovsky,
Wayne T Smith,
Whitney S Reynolds,
William C Brenneman,
William W Dotts,
Xinyi Hui,
Yessika Mashinski
Derek S Dealy's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2016 | FDA 483 | IVD, LLC - Form 483, 2016-04-22 |
February, 2017 | EIR | Catalent Pharma Solutions, LLC - EIR, 2017-02-01 |
August, 2014 | EIR | JBS Souderton, Inc. dba MOPAC - EIR, 2014-08-06 |
September, 2014 | FDA 483 | High Chemical Company, Div of National Generic Distributors - Form 483, 2014-09-05 |
October, 2014 | EIR | Johnson & Johnson Consumer Products Company - EIR, 2014-10-03 |
August, 2014 | FDA 483 | JBS Souderton, Inc. dba MOPAC - Form 483, 2014-08-06 |
October, 2014 | FDA 483 Response | Johnson & Johnson Consumer Products Company - Form 483R, 2014-10-23 |
July, 2018 | EIR | World Nutrition, Inc. - EIR, 2018-07-27 |
April, 2016 | EIR | IVD, LLC - EIR, 2016-04-22 |
June, 2017 | FDA 483 | Prime Packing Partners LLC - Form 483, 2017-06-27 |
October, 2014 | FDA 483 | Johnson & Johnson Consumer Products Company - Form 483, 2014-10-03 |
March, 2023 | EIR | Nestle Mexico, S.A. de C.V. - EIR, 2023-04-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more